Accumulation of neurobiological knowledge points to neurodevelopmental origins for certain psychotic and mood disorders. Recent landmark postmortem reports implicate Reelin, a secretory glycoprotein responsible for normal lamination of brain, in the pathology of schizophrenia and bipolar disorders. We employed quantitative immunocytochemistry to measure levels of Reelin protein in various compartments of hippocampal formation in subjects diagnosed with schizophrenia, bipolar disorder and major depression compared to normal controls. Significant reductions were observed in Reelin-positive adjusted cell densities in the dentate molecular layer (ANOVA, P Ͻ 0.001), CA4 area (ANOVA, P Ͻ 0.001), total hippocampal area (ANOVA, P Ͻ 0.038) and in Reelin-positive cell counts in CA4 (ANOVA, P Ͻ 0.042) of schizophrenics vs controls. Adjusted Reelin-positive cell densities were also reduced in CA4 areas of subjects with bipolar disorder (ANOVA, P Ͻ 0.001) and nonsignificantly in those with major depression. CA4 areas were also significantly reduced in schizophrenic (ANOVA, P Ͻ 0.009) patients. No significant effects of confounding variables were found. The exception was that family history of psychiatric illness correlated strongly with Reelin reductions in several areas of hippocampus (CA4, adjusted cell density, F = 13.77, P = 0.001). We present new immunocytochemical evidence showing reductions in Reelin expression in hippocampus of subjects with schizophrenia, bipolar disorder and major depression and confirm recent reports documenting a similar deficit involving Reelin expression in brains of subjects with schizophrenia and bipolar disorder. Molecular Psychiatry (2000) 5, 654-663.
Introduction
Reelin is a secretory glycoprotein with a relative molecular mass of about 400 kDa 1 and encoded by a long mRNA of 12 kilobases. 2, 3 The aminoterminus of Reelin is 25% identical to that of F-spondin, 3 a protein secreted by the floor plate of the spinal cord and thought to regulate the adhesion and extension of commissural axons, 4 and to tenascin. 5 Reelin plays several important roles during embryonic development of the brain such as guiding the normal migration of neurons, 6 correct lamination of cortex 7 and a modulatory role during the formation of layer-specific connections in the hippocampus. 8 Recent reports also indicate that Reelin promotes maturation of single fibers and synaptogenesis by entorhinal afferents 8 but may also modulate dendritic spine dynamics in adult brain.
Postmortem studies by Costa and coworkers, [10] [11] [12] [13] have revealed a 50% reduction in Reelin mRNA and protein in several brain areas in schizophrenic and psychotic bipolar patients. These studies support other reports, which implicate schizophrenia as a neurodevelopmental encephalopathy. 14, 15 We will present new immunocytochemical data evincing a pathological involvement of the Reelin molecule in the hippocampus of subjects with schizophrenia and bipolar disorder, and major depression.
Materials and methods

Tissue
Frozen postmortem samples of ventral hippocampus were obtained from the Stanley Foundation Neuropathology Consortium 16 under approved ethical guidelines. The collection consisted of 15 subjects with schizophrenia, 15 with bipolar disorder, 15 with major depression without psychotic features and 15 normal controls. All groups were matched for age, sex, race, postmortem interval and hemispheric side ( Table 1 ). All demographic information and medical data including lifetime use of psychotropic medications and his- tory of drug abuse were provided to us by the Stanley Foundation Consortium (Tables 1 and 2 ). Psychiatric diagnoses had been established by two psychiatrists using DSM-IV criteria. All experiments were performed blinded to the diagnosis of each subject.
Immunocytochemistry Frozen 14-m thick coronal sections from ventral hippocampus were stored at −86°C. Three to five sections of either right or left hemispheric hippocampal cortex per brain were used. On the day of the experiment, sections were warmed to room temperature (RT) and air dried for 2 h. Later, sections were hydrated in Tris-HCl buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.6) twice for 5 min each and then fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS, 10 mM sodium phosphate, 150 mM NaCl, pH 7.4) for 60 min at 4°C. Sections were then washed in Tris buffer for 5 min three times, and later immersed in 0.009% H2O2 in methanol for 30 min at RT. Sections were washed again in Tris buffer, three times for 5 min each at RT.
Reelin antigenic sites were enhanced several-fold following a modification of Pesold et al's 17 and Impagnatiello et al's 10 techniques as follows: Reelin antigenic sites were retrieved by microwaving sections in Antigen Retrieval Citra Solution (Biogenex, pH 6.0) for 3 min at power 9, followed by 5 min at power 1 (General Electric microwave oven model JE285 1 H, electric output 700 W). Sections were later cooled in Tris buffer for 15 min at RT. Later, sections were immersed in a blocking solution containing 3% normal horse serum (NHS) in Tris buffer for 30 min at RT. Following draining of blocking solution, monoclonal antiReelin antibody No. 142 (gift of Dr Goffinet) 18 at 1:500 dilution in 1% NHS/Tris was added to slides and incubated in a humidified chamber for 12 h at 4°C. This antibody recognizes the N-terminal Reelin epitope (amino-acids 164-189) and has been well characterized biochemically by Goffinet and coworkers. Following primary antibody incubation, sections were washed several times in Tris buffer (3 × 5 min RT) and exposed to biotinylated horse antimouse IgG (Vector Labs, Burlingame, CA, USA) at Ϸ 1:200 dilution in 1.5% NHS/Tris for 30 min at RT. Immune complexes were incubated in the Vecta Stain Elite ABC reagent (Vector
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Labs), 30 min RT. After being washed in Tris buffer for 5 min, the sections were stained for 8 min at RT with 3,3Ј-diaminobenzidine and nickel chloride with use of the DAB substrate kit (Vector Labs). The reaction was stopped in dH 2 O. Slides were then dehydrated through graded alcohol series and xylene, and coverslipped in permount before examination with a Nikon Labophot-2 microscope (Fryer Co, IL, USA) under bright light field.
One section per experiment was run as a negative control (no primary antibody) which did not exhibit any immunostaining. Moreover, adjacent sections were stained with cresyl violet and with anti SNAP-25 monoclonal antibody for anatomic examination of hippocampus and to further ensure specificity of Reelin immunostaining. The patterns of staining with antiReelin antibody varied from that using anti-SNAP-25 antibody. Reelin-positive cell bodies exhibited black staining of cytoplasm and showed horizontal dendritic extensions. Reelin-positive cells were seen in all layers of the hippocampus, but were more numerous in stratum moleculare of hippocampus and the dentate gyrus and hilar area (CA4 of hippocampus). Reelin-positive cells were generally round or ovoid and easily discernible. Occasionally polymorphic positive cells were identified in hilar areas and were included in counts. All cell counts were performed using the Micro-Bright Field Stereoinvestigator software (Burlington, VT, USA). Immunostaining of brain sections with antiReelin antibody 142 provided a pattern which separated the hippocampal layers longitudinally, such that the following five boundaries became easily discernible:
(a) The unstained alveus was localized next to a band of Reelin-positive extracellular matrix, staining stratum oriens. This corresponded to compartment 1. (b) The unstained strata pyramidale, radiatum, and lucidum corresponded to compartment 2. (c) Reelin-positive extracellular matrix was localized over the hippocampal molecular layer next to the hippocampal fissure corresponding to compartment 3. (d) The Reelin-positive extracellular matrix was localized over the dentate molecular layer 
layer 3 layers 2 and 3 r = −0.367, P Ͻ 0.005 r = −0.117, P = 0.386
layers 4,5 and layer 5 layer 2 and total hippocampus r = −0.380, P Ͻ 0.004 total hippocampus (including inner and outer sublayers) just next to the granular cell layer, all corresponding to compartment 4. (e) The dentate hilus or CA4 area was dotted by many Reelin-positive cells localized mostly subjacent to the granular layer. The CA4 boundary consisted of a space adjoined by the granular cell layer and a line connecting the two blades of the granular cell layer. This area corresponded to compartment 5.
Hippocampal areas were then measured using the Micro-Bright Field Stereoinvestigator and included the following compartments: compartment 1 corresponding to alveus and stratum oriens; compartment 2 corresponding to stratum pyramidale, stratum radiatum and stratum lucidum; compartment 3 corresponding to hippocampal stratum moleculare; compartment 4 corresponding to inner and outer molecular layers of dentate gyrus as well as dentate granular layer; and compartment 5 corresponding exclusively to hilus of dentate or area CA4 of hippocampus. All area measurements were obtained in mm 2 ± SD. In general, two to four slides were used for all cell counts per brain except for one subject in the depressed group where only one section was available for counting purposes. Reelinpositive cell counts were converted to adjusted cell densities as follows: Reelin-positive cell counts were divided by each corresponding hippocampal area resulting in Reelin-positive cell densities. Later, cell densities were converted to adjusted cell densities in each experimental hippocampal area taking into account changes in areas measured in psychiatric hippocampi as compared to control values, ie Reelin-positive cell density divided by correction factor (correction factor = control area measured (mm 2 ) ÷ experimental area measured (mm 2 )) resulting in adjusted cell density.
Statistical analyses
Statistical analysis of data was performed using SAS/STAT v.6 software (Cary, NC, USA) and SPSS v.8.0 software (Chicago, IL, USA). Area measurements, cell counts and adjusted cell density values were subjected to a repeated measures analysis. In case of significance, separate one-way analysis of variance (ANOVA) was performed to test differences among the four diagnostic groups for each hippocampal compartment (compartments 1-5, and total hippocampus). ANOVAs with a significant main effect (ie, P Ͻ 0.05) were followed by standard post hoc testing (Tukey Honest Significant Difference Test (Tukey's HSD test)) for further examination of group differences. Several possible confounders (age, sex, PMI, side of brain, mode of death, history of medication or drug use, duration of disease, age of onset of disease, family history of psychiatric disease, pH of brain, freezer storage time, subtype of schizophrenia, subtype of bipolar disorder (psychotic vs nonpsychotic)) were tested for differences across groups and for their effects on Reelin-positive cell counts, adjusted Reelin-positive cell densities and hippocampal areas (Tables 1 and 2 ). Finally, for group differences on age, age of onset, PMI, brain pH and freezer storage time, ANOVA was used, producing F and P values. For group differences on the other variables, Chi-squared tests were used. For effects of age, age of onset, PMI, brain pH and freezer storage time on cell counts, areas and adjusted cell densities, correlation values and probabilities (r and P) were computed. For analysis of effects of categorical variables on cell counts, areas, and adjusted cell densities, repeated measures ANOVA was used, producing F and P values (Tables 1 and 2 ).
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Results
Reelin-positive cells were identified and counted in various layers of the hippocampus and dentate gyrus. Reelin-positive cells were observed in hippocampi of all groups and did not vary in shape between diagnostic groups (see Image section). Reelin-positive cells were more numerous in molecular and hilar layers of hippocampus in all brains. There was, however, more variation in the shape of Reelin-positive cells in the hilar areas vs other hippocampal layers; namely, immunopositive cells were larger and more polymorphous (Image). In all cases, Reelin-positive cells with dense staining were counted (Image).
Quantitative assessment of Reelin-positive cells showed significant differences in the number of these cells in the dentate molecular layer (compartment 4) of schizophrenic hippocampi as compared to controls (Table 3 , P Ͻ 0.05). The cell counts in schizophrenic hippocampal areas corresponding to alveus and st. oriens (compartment 1), as well as st. pyramidale, st. radiatum and st. lucidum, (compartment 2) were lower by 26 and 19% respectively, when compared to controls; these values were not, however, statistically significant (Table 3) . By the same token, hilar (CA4, compartment 5) and total hippocampal Reelin-positive cell count in schizophrenics were lower by 45% and 27% respectively vs controls, without attaining any statistical significance (Table 3, Figure 1 ).
Reelin-positive cell counts were converted to adjusted cell densities taking into account changes in areas measured in schizophrenic hippocampi when compared to control values (Tables 4 and 5 ). Quantification of adjusted cell densities showed consistently lower Reelin-positive adjusted cell densities in all of the schizophrenic hippocampal layers when compared with control values (Table 4) . Overall, there were reductions of 30%, 18%, 5%, 45%, 42% and 29% in schizophrenic Reelin-positive adjusted cell densities in compartments 1-5 and in total hippocampus respectively vs controls with dentate molecular/granular layer (compartment 4), hilar (CA4) and total hippocampal layers being statistically significant (ANOVA, P Ͻ 0.001, P Ͻ 0.001, P Ͻ 0.038 respectively, Table 4 , Figure 2 ). Area measurements of hippocampal layers showed statistically significant reductions in schizophrenic hilar areas as compared to controls (ANOVA, P Ͻ 0.009, Table 5 ). The schizophrenic area measurements for compartments 1, 2, 4 and for total hippocampus, despite reductions of 30%, 9%, 40% and 21% vs control values, were not statistically significant ( Table 5 ). Comparison of schizophrenic compartment 4 (dentate inner and outer molecular/granular layer) and total hippocampus vs major depressed values respectively showed significant reductions in the former values (ANOVA, P Ͻ 0.005, P Ͻ 0.034 respectively, Table 5 ).
In the bipolar patients, Reelin-positive cell counts also decreased in most hippocampal compartments by 30% (1), 26% (2), 26% (4), 27% (5) and 15% (total hippocampus) when compared with control values. However, none of these reductions attained statistical significance. A similar pattern of decrease was also seen in Reelin-positive adjusted cell densities in bipolar patients when compared to control values (Table 4) . However, dentate inner and outer molecular/granular and hilar values were considered statistically significantly reduced (ANOVA, P Ͻ 0.001, P Ͻ 0.001 respectively) vs controls ( Figure 2 , Table 4 ). Area measurements showed non-statistically significant decreases in four bipolar areas (except for compartments 2 and 3) ranging from 3% to 39% vs controls (Table 5) . Finally, Reelin-positive cell counts showed consistently lower values in all hippocampal compartments (42%, 26%, 1%, 17%, 21%, 19% for compartments 1, 2, 3, 4, 5 and total hippocampus respectively) of subjects with major depression, albeit without statistical significance (Table 3) , when compared to control values. By the same token, all depressed Reelin-positive adjusted cell density values showed reductions of 25%, 28%, 6%, 20%, 27.3% and 21% when compared to control values. None of these values were statistically significant when compared to controls (Figure 2 , Table 4 ). Area measurements in depressed hippocampal layers did not vary significantly from control values (Table 5) .
Age was negatively correlated with area measurements in compartments 2 and 3 and with Reelin-posi- tive cell count in compartment 3. Postmortem interval was negatively correlated with area measurement in the CA4 region, with Reelin-positive cell counts in compartments 4, 5 and in total hippocampus, and with adjusted Reelin-positive cell densities in compartment 2 and total hippocampus (Table 2) . However, the four diagnostic groups did not significantly differ by age or by PMI (Tables 1 and 2) , and thus these factors were not considered to be potential confounders. None of densities, Table 2 ). Thus, the lack of family history in the control group may be one explanation for their higher cell counts and cell densities when compared to other diagnostic groups. However, when control values were excluded from analysis, family history effect was evenly distributed across the other three groups, and it no longer had a significant effect on cell count (F = 3.364, P = 0.064) but it still had an effect on adjusted cell density values (F = 6.577, P = 0.014). For freezer storage time, the bipolar and schizophrenic groups had significantly larger values (46.5 and 46.4 months, respectively) than the controls (ෂ37.2 months). Additionally, freezer storage time was significantly negatively correlated with area measurements in layers 1 and 4 ( Table 2 ) and significantly positively correlated with cell counts and adjusted cell density values in layer 3 (Table 2) . What this suggests is that storage time may be a confounder with respect to the difference between bipolars, schizophrenics and controls on area measurement in layers 1 and 4 (and not in layer 5 or the CA4 area which is significantly reduced vs controls). However, freezer storage time could not be a confounder with respect to cell counts and adjusted cell densities in layer 3, because it would have predicted a group difference going in the opposite direction to what was actually found.
Discussion
The present results support and extend Costa's findings of decreased Reelin protein levels in schizophrenic and bipolar brains. [10] [11] [12] Moreover, these results show, for the first time, that reduction in Reelin protein is also present in the hippocampus of patients with major depression. Additionally, there is reduction in the hilar area of hippocampus in schizophrenic and bipolar patients. Reelin deficiency was present to the same extent in schizophrenic and bipolar patients since Reelin-positive cell counts were reduced in most areas of hippocampus and dentate gyrus vs controls. Moreover, expression of Reelin-positive cell counts as a function of hippocampal areas (or adjusted cell density values), measured in schizophrenic and bipolar patients, showed reductions in Reelin protein levels in all hippocampal compartments (except for compartment 3 in bipolar subjects) as compared to controls. The reductions in Reelin protein were more pronounced in hilar areas of hippocampus in all psychiatric patient groups, because classically, these are the target sites for most reported pathologies 19 encountered in schizophrenic and bipolar brains. Moreover, the molecular and hilar areas in hippocampus represent the anatomic areas with the highest number of Reelinpositive interneurons and Cajal-Retzius cells. 14, 20 By the same token, reductions in Reelin protein and mRNA in frontal and temporal cortices reported by Costa and coworkers [10] [11] [12] were also limited exclusively to laminae I and II which also contain the highest number of Reelin-positive cell bodies. Since hippocampal CA4 area measurements were greatly reduced in schizophrenic and bipolar patients (by 45% and 39% respectively), normal cell density estimations without correction for control area measurements would produce artificially inflated values masking the deficits in Reelin protein expression. Similarly, if cell values for Reelin expression were analyzed based on constant area measurements without knowledge of tissue atrophy, cell density values would be misleadingly elevated and represent a totally erroneous outcome ie, no change or increase in Reelin levels in schizophrenic and bipolar brains. This may be one reason why smaller reductions in Reelin expression such as seen in depressed hippocampal tissues (where no apparent tissue atrophy is present), would be obscured if values examined were based solely on normally calculated cell densities. This confounding variable is more of a problem when dealing with brain areas such as frontal, temporal or occipital cortex where exact volumetric or area measurements, as done in this study, cannot be obtained from few selected brain sections. This variable is not as problematic when dealing with brain areas such as hippocampus where anatomic boundaries are easily discernible and comparisons can be made with more accuracy between psychiatric and control brain sections. We believe this may be one reason why reductions in Reelin levels in depressed patients were detected in this study while not observed in reports by Costa and coworkers. 10, 11 A further variable explaining the discrepancy between our data regarding Reelin changes in depressed patients vs Costa's may be related to our use of immunocytochemical methods in hippocampus (a site with significant differences in population of interneurons vs frontal or cerebellar cortex) vs Western blotting techniques used by the latter 10 in hippocampus. Thus, immunocytochemical and cell counting techniques used by us and Costa's group resulted in closer estimations of Reelin reductions in both schizophrenic and bipolar patients ie, 20-30% reductions (frontal cortex laminae I and II) reported by Guidotti et al 12 vs 32-45% (hippocampal dentate molecular and hilar areas) as seen in this study. Alternatively, Reelin reductions in depressed patients may be due to other variables not evaluated in this study such as effects of antidepressant medications. However, this is less likely since psychotropic medications were not shown to have any impact on Reelin levels, both in this study and in reports by Costa and coworkers. [10] [11] [12] A further mechanism operational in depressed brains may involve normal mRNA levels for Reelin in association with either defective processing of Reelin protein leading to decreased synthesis of this molecule (a scenario analogous to Orlean's reeler mutation where Reelin secretion is defective 18 ), or selective Reelin-positive GABAergic cell loss. Finally, a less likely mechanism explaining the reduced numbers of Reelin-positive cells in all psychiatric brains may be due to an overall decrease in neuronal density in the respective brain samples. This possibility is unlikely given that, at least for schizophrenia, there is no conclusive evidence of decreased neuronal density in this disorder. 21 Evidence of neuronal density decreases in bipolar and depressed hippocampus is however, currently lacking.
Moreover, we did not detect any association between presence or absence of psychosis and Reelin levels, since Reelin values in four bipolar patients without psychosis were reduced similar to psychotic bipolar patients and schizophrenic patients. Thus, it is not clear if decreased Reelin levels seen in this study can be used to predict the presence of psychotic symptoms. However, Reelin has clear-cut neurodevelopmental roles during brain development in man and mice. 6, 7, 9 Absence of Reelin during embryogenesis can lead to abnormal cortical lamination defects as seen in homozygous reeler mutant mice. 6 Additionally, reduction in
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Reelin during embryogenesis in mice prenatally infected with human influenza virus can also result in abnormal corticogenesis. 22 It is also evident that variable expression of Reelin levels in brain may lead to abnormal behavioral developments as recently shown in heterozygous reeler mutant mice 23 which do not exhibit abnormal cortical laminar defects, but demonstrate prepulse inhibition (PPI) abnormalities. This latter point has relevance to our findings of reduced Reelin protein levels in hippocampus of subjects with major depression who do not manifest any obvious atrophy of hippocampal tissue and may not exhibit other cortical structural defects as seen in schizophrenic and bipolar subjects, [23] [24] [25] [26] but may share development of psychotic or other behavioral abnormalities with schizophrenia. It is possible that graded deficits in levels of Reelin may cause variable levels of brain synaptic and behavioral abnormalities, ie while total absence of Reelin, such as seen in homozygous reeler mutant mouse 6 can cause pronounced cortical defects, lesser deficiencies lead to milder structural and behavioral problems (seen in schizophrenic and bipolar brains, or following prenatal viral infection in mice 22 vs haploinsufficiency in Reelin levels seen in heterozygous reeler mutants 23 ). Recent reports 8, 11 also indicate that Reelin deficiency may be associated with decreased synaptic transmission and reduced learning and memory in psychiatric patients. This may have relevance to our findings of decreased Reelin levels in schizophrenic, bipolar and depressed patients who regardless of presence or absence of psychosis may exhibit signs of decreased cognitive abilities especially as related to memory and learning processes. This is also analogous to a recent report 27 showing that a decrease of NMDA R1 receptor level to 5-10% of control levels in mice leads to genesis of social behavioral abnormalities in adult mutant mice which are comparable to symptoms seen in schizophrenic patients. Additionally, the role of Reelin in adult mammals is not known presently. There is increasing evidence to indicate that Reelin may have multiple important functions in adult mammals, because of the presence of several putative receptors (VLDL, 28 integrin 9,29 ) for this interesting molecule. Moreover, Reelin is present in blood 11 and is composed of several isoforms whose true functions and physiological roles are not known. 30 Recent electron microscopic data by Rodriguez et al 9 indicate that Reelin is colocalized with the ␣3 integrin receptor in postsynaptic densities present in apical dendrites of pyramidal neurons, alluding to their potential involvement in learning and memory processing. These results offer a potential scenario whereby decreased neuropil 21 and reduced dendritic spine density, observed in various brain sites in schizophrenic brains, may be related to a downregulation of Reelin-integrin interactions with consequent dysfunction in long-term potentiation and learning, problems frequently encountered in schizophrenic patients. A further scenario which supports the GABA downregulation hypothesis of schizophrenia is the reported deficiency in Reelin and glutamic acid decar-boxylase 67-kDa 10, 12 (GAD-67) protein and mRNA in prefrontal and cerebellar cortices of schizophrenic and psychotic bipolar patients. These decreases in GAD-67 mRNA and protein were not caused by any confounding variables such as PMI, dose, duration or presence of antipsychotic medications and have now been corroborated by similar findings in two other studies. 31, 32 An interesting finding in this study is the presence of significant decreases in Reelin levels in CA4 areas of all psychiatric brains. Hippocampal CA4 is an important anatomic crossroad for innervation by perforant and mossy fiber pathways connecting hippocampus with several other sites in the brain. Moreover, hilus is the exclusive subdivision of hippocampus, where many of the purported molecular abnormalities seen in schizophrenia take place, ie reduced expression of mRNA for various subunits of non-NMDA glutamate receptors, for synaptophysin, GAP-43 and CCK. 19 Additionally, there are reductions in levels of several brain markers such as PSA-NCAM, BDNF, LAMP and SNAP-25 in CA4 area of hippocampus. 19 Reduced CA4 area, as seen here, would further decrease the normal capacity of this region for better synaptic connectivity to other regions of the hippocampus and to other brain sites in schizophrenic and bipolar patients who are already predisposed to decreased levels of Reelin.
In conclusion, we have provided new immunocytochemical evidence showing reductions in Reelin expression in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Additionally, we confirm previous reports 10, 12 documenting a similar molecular deficit involving Reelin expression in brains of subjects with schizophrenia and bipolar disorder. Future studies should investigate whether Reelin deficiency is a common mechanism for some of the shared behavioral/psychotic symptoms present in these three psychiatric disorders and should provide additional evidence for its pathologic involvement in other neuropsychiatric disorders.
